Allogeneic Cellular and Autologous Stem Cell Therapy for Sickle Cell Disease: ‘Whom, When and How’

Bone Marrow Transplantation - United Kingdom
doi 10.1038/bmt.2011.245
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy